Social Purpose Corporation Statement (2018) Antimicrobial resistance threatens the very core of human healthcare. ID Genomics’ Social Purpose is simple: to limit bacterial resistance and preserve antibiotics for the good of mankind. We believe that antimicrobial resistance connects every [...]
Today, Seattle-based ID Genomics, Inc.was awarded a grant from the Longitude Prize Discovery Awards, a seed funding program to help teams competing to win the prestigious Longitude Prize. Run by innovation foundation Nesta and supported by Innovate UK as funding partner, the Longitude Prize is a [...]
Many thanks to Clare McGrane at Geek Wire for her narrative describing ID Genomics’ fingerprinting technology. Please read the full article at the link provided here [...]
ID Genomics and the University of Washington have long collaborated on developing cutting-edge technology that improves prescriptions of antibiotics for infectious diseases. To find out more about this collaboration, please read the UW Daily’s account of our technology here: [...]
Many thanks to the Seattle Times for its coverage of ID Genomics’ technology. Please read the full text here: Seattle health startup speeds up lab tests to improve use of antibiotics [...]
SEATTLE (March 29, 2017) Newly published, peer-reviewed results of observational clinical research have demonstrated that ID Genomics’ “bacterial fingerprinting” technology has the potential to improve antibiotic prescribing, reducing prescription errors and the overuse of broad-spectrum [...]
ID Genomics will present its pitch in MedTech Innovators’ lightning round on March 15th. Thanks to Wings and Life Sciences Washington for the opportunity! MedTech Innovator [...]
ID Genomics will present a booth advertising its genomics’ Services at Alliance Northwest (http://alliancenorthwest.org). We have been proudly offering Services such as 16S rRNA typing, MultiLocus Sequence Typing, antibiotic susceptibility testing, and Staphylococcus aureus SPA typing to [...]
IDG will present its work at the 13th Annual NIH CAP FeedForward(TM) Sessions. We thank the LARTA Institute for this opportunity and welcome mentor feedback! http://www.larta.org [...]
The Company’s novel approach in matching the infecting bug with the correct drug the first time has been covered by Modern Healthcare: Innovations. Please read the entire text [...]